Alzheimer’s disease remains one of the most pressing neurological health concerns, particularly among older Hispanic populations. In states like Florida, where the density of Latino seniors is high, dementia cases have seen a consistent rise. Recent research shows that this group has up to 50% higher prevalence of Alzheimer’s compared to other demographics.
There are risk factors that, while not entirely preventable, can be modified through healthy habits. Uncontrolled hypertension, high cholesterol, smoking, obesity, sedentary lifestyle, chronic sleep deprivation, excessive alcohol consumption, and social or cognitive isolation significantly increase the likelihood of cognitive decline. Addressing these issues through personalized prevention strategies can reduce the risk of developing dementia by up to 45%.
One of the most important diagnostic breakthroughs is the approval of PET scans to detect brain amyloid, a key substance in Alzheimer’s progression. This technology, now covered by Medicare, enables early and accurate detection of the disease—dramatically improving the chances for timely treatment.
Additionally, since 2024, a groundbreaking blood test called p-tau 217 has become available. It detects specific Alzheimer’s biomarkers with over 90% sensitivity and can support diagnosis in patients with cognitive symptoms. Although not recommended for general preventive screening, its clinical value is high when confirming early-stage Alzheimer’s.
At Medical Arts Neurology, the team is dedicated to the prevention, diagnosis, and comprehensive treatment of Alzheimer’s. By combining evidence-based practices with advanced technology, they provide effective therapeutic options and support for both patients and their families.
Book an Appointment